Rotella Capital Management, Inc. - SKYSTAR BIO-PHARMA CO ownership

SKYSTAR BIO-PHARMA CO's ticker is SKBI and the CUSIP is 830884300. A total of 15 filers reported holding SKYSTAR BIO-PHARMA CO in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Rotella Capital Management, Inc. ownership history of SKYSTAR BIO-PHARMA CO
ValueSharesWeighting
Q1 2015$70,000
-48.9%
18,026
-44.5%
0.06%
-50.4%
Q4 2014$137,000
-2.1%
32,493
-2.7%
0.12%
-19.0%
Q3 2014$140,000
+10.2%
33,393
+93.1%
0.15%
+36.1%
Q2 2014$127,00017,2930.11%
Other shareholders
SKYSTAR BIO-PHARMA CO shareholders Q2 2015
NameSharesValueWeighting ↓
Rotella Capital Management, Inc. 33,393$140,0000.15%
SABBY MANAGEMENT, LLC 289,110$1,211,0000.05%
Spark Investment Management LLC 21,400$89,0000.01%
ClariVest Asset Management LLC 19,720$82,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 24,300$102,0000.00%
EAGLE GLOBAL ADVISORS LLC 22,576$95,0000.00%
Renaissance Technologies 14,600$61,0000.00%
MORGAN STANLEY 8,514$36,0000.00%
BlackRock Institutional Trust Company, N.A. 175,808$737,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 15,900$67,0000.00%
View complete list of SKYSTAR BIO-PHARMA CO shareholders